Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

Conclusions
Long-term, extended dosing of DA maintained Hb concentrations in patients already treated with an ESA and corrected and maintained Hb in ESA-naïve patients.

Source: Nephrology Dialysis Transplantation - December 7, 2016 Category: Urology & Nephrology Authors: Galle, J.-C., Addison, J., Suranyi, M. G., Claes, K., Di Giulio, S., Guerin, A., Herlitz, H., Kiss, I., Farouk, M., Manamley, N., Wirnsberger, G., Winearls, C. Tags: Chronic Kidney Disease Source Type: research